In Brief
Poon et al. identify a role for the Hippo pathway in regulating neuroblast cell proliferation to control brain size. The Hippo pathway restricts neuroblast cellcycle speed and cell size, and it controls timely entry and exit from neurogenesis, revealing a novel mechanism that limits stem cell proliferative potential in brain development.
A key question in developmental neurobiology is how neural stem cells regulate their proliferative potential and cellular diversity and thus specify the overall size of the brain. Drosophila melanogaster neural stem cells (neuroblasts) are known to regulate their ability to self-renew by asymmetric cell division and produce different types of neurons and glia through sequential expression of temporal transcription factors [1] . Here, we show that the conserved Hippo pathway, a key regulator of epithelial organ size [2] [3] [4] , restricts neuroblast proliferative potential and neuronal cell number to regulate brain size. The inhibition of Hippo pathway activity via depletion of the core kinases Tao-1, Hippo, or Warts regulates several key characteristics of neuroblasts during postembryonic neurogenesis. The Hippo pathway is required to maintain timely entry and exit from neurogenesis by regulating both neuroblast reactivation from quiescence and the time at which neuroblasts undergo terminal differentiation. Further, it restricts neuroblast cell-cycle speed, specifies cell size, and alters the proportion of neuron types generated during postembryonic neurogenesis. Collectively, deregulation of Hippo signaling in neuroblasts causes a substantial increase in overall brain size. We show that these effects are mediated via the key downstream transcription co-activator Yorkie and that, indeed, Yorkie overexpression in neuroblasts is sufficient to cause brain overgrowth. These studies reveal a novel mechanism that controls stem cell proliferative potential during postembryonic neurogenesis to regulate brain size.
RESULTS AND DISCUSSION
The Hippo Pathway Functions in Larval Neuroblasts to Restrict Brain Size During brain development, neural stem cells (NSCs) undergo recurring self-renewing asymmetric cell divisions to produce another neuroblast and a smaller daughter cell, the ganglion mother cell (GMC), that divides once more and differentiates into neurons or glia. NSCs must coordinate cell-cycle entry and exit with developmental timing to ensure that the correct number and type of neurons are specified in a strict temporal sequence. Deregulation of NSCs can give rise to either an undersized or overgrown brain and is respectively associated with microcephaly or the formation of brain tumors (such as medulloblastoma) [5, 6] . Many aspects of NSC control, including mode of cell division, proliferation, and differentiation, are highly conserved between vertebrates and invertebrates [5] [6] [7] [8] . In Drosophila melanogaster, the larval CNS possesses two types of progenitor cell: the neuroepithelium and neuroblasts. The neuroepithelium resides in the optic lobes and gives rise to medulla neuroblasts, whereas neuroblasts of type I and type II lineages reside in the central brain and ventral nerve cord. The ultimate number of progeny, and therefore finite adult brain size, is governed by the neuroblast's ability to divide asymmetrically, its proliferation rate, and its timely entry into and exit from postembryonic neurogenesis, a period that spans larval and early pupal stages.
The Hippo pathway is a major regulator of organ size and can be sub-classified into upstream regulators, the core kinase cassette, and downstream transcriptional regulators [2, 4, 9] . It is known to regulate the proliferation of two cell populations in the larval D. melanogaster brain: glia and the neuroepithelium [10] [11] [12] . Although the Yorkie (Yki) transcription co-activator was recently linked to neuroblast biology downstream of the Lkb1 and AMPK kinases [13] , a role for the Hippo pathway core kinases in control of neuroblasts, the stem cell population that produces 90% of adult brain cells, has not been reported. To investigate the Hippo pathway in brain development, we surveyed expression of key Hippo pathway proteins in the third-instar larval brain using endogenously tagged alleles of the kinases tao-1 and hippo (hpo) and a Yki antibody ( Figure S1 ). All three proteins were expressed throughout the larval brain and were present in neuroblasts ( Figure S1 ).
To test the functional significance of the Hippo pathway in neuroblasts of the developing brain, we modulated Hippo pathway activity using RNAi driven by the inscuteable-Gal4 driver, which is expressed in type I and type II neuroblasts throughout postembryonic neurogenesis [14] . Compared with control age-matched brains, when Tao-1 was depleted by RNAi, we observed a 2-fold increase in overall brain volume at the mid-third-instar larval stage ( Figures 1A, 1B , and 1E). We have previously validated the efficacy of the tao-1 RNAi line in wing imaginal discs [15] . We observed similar results when we depleted Tao-1 using three additional independent RNAi lines ( Figure S2A) ; substantial variability in volume was observed within each experiment, suggestive of variable penetrance of Figures 1F-1I) , suggesting that the Hippo pathway restricts the growth output of ventral nerve cord neuroblasts. We examined central brain tao-1 RNAi MARCM clone volume (derived from type I neuroblasts) and found that although there was a trend toward an increase in GFP + volume, there was no statistically significant change compared to control ( Figures S2B-S2D ). This was consistent with recent studies that found that Hippo pathway core kinases do not regulate central brain neuroblast proliferation potential [10, 13] . Therefore, we focused our analysis on type I neuroblasts of the ventral nerve cord for the remainder of this study.
The Hippo Pathway Inhibits Cell-Cycle Entry from Quiescence Perturbation of Hippo signaling could feasibly increase brain volume in several ways: (1) an expansion of the postembryonic neurogenesis period, which defines the length of developmental time that each neuroblast is engaged in the cell cycle [20, 21] ; (2) an expansion of neuroblast numbers due to misregulation of neuroblast self-renewal and differentiation causing uncontrolled proliferation [22] [23] [24] ; or (3) an increase in neuroblast cell-cycle speed, which would give rise to additional progeny.
Initially, we tested whether Hippo pathway modulation affected neuroblast reactivation from quiescence. Many stem cells, in both D. melanogaster and mammals, undergo periods of quiescence followed by reactivation into the cell cycle [25] [26] [27] [28] . The balance between stem cell quiescence and proliferation is an important determinant of organ size and function. D. melanogaster neuroblasts enter into quiescence at the end of embryonic neurogenesis and are reactivated from the latefirst-instar (L1) stage onward, subject to a nutritional checkpoint requiring dietary amino acids [29] . Neuroblast reactivation occurs in a stereotypical spatiotemporal pattern along the anteriorposterior axis, reactivating first in the optic lobes followed by the ventral nerve cord as neurogenesis progresses during larval development [6, 30] .
To determine whether the Hippo pathway regulates neuroblast reactivation, we labeled late-L1/early-second-instar (denoted L1-L2) brains expressing either control RNAi or tao-1 RNAi driven by inscuteable-Gal4 with EdU for 1 hr to mark cells in S phase. fashion. Therefore, these results suggest that, in addition to the dietary requirement of the Target of Rapamycin and Insulin signaling pathways [30, 31] , Hippo signaling also regulates neuroblast quiescence and timely cell-cycle re-entry. Prior to exit from quiescence and re-entry into the cell cycle, both D. melanogaster neuroblasts and mammalian neural stem cells from the developing cortex undergo a prerequisite period of cell enlargement [20, 30, 32] . Given that Hippo-pathwaydeficient neuroblasts prematurely exited from quiescence, we predicted that they would also be larger than age-matched control neuroblasts. To test this, we assessed the average cell diameter of neuroblasts (marked by Miranda [Mira]; Figures  2C-2E ) in L1-L2 brains. Indeed, neuroblasts deficient for Tao-1 were, on average, 1.3-fold larger than control neuroblasts (Figure 2E) , consistent with our observation that they exit quiescence prematurely.
To determine the developmental profile of growth and proliferation caused by Hippo pathway repression in neuroblasts, we examined mid-second-instar (mid-L2) and late-second-instar/ early-third-instar (denoted L2-L3) brains and assessed brain size and S phase cells (indicated by EdU incorporation). At each time point, compared with control brains, Tao-1 depletion in neuroblasts resulted in consistently increased brain volume and proliferation (Figures 2F-2K ). These data suggest that Tao-1 is required beyond initial neuroblast reactivation to limit neuroblast proliferation rate and overall brain size as development progresses.
The Hippo Pathway Promotes Timely Neuroblast Differentiation
In the ventral nerve cord, neuroblasts remain proliferative until $24 hr after puparium formation (APF), whereupon the transcription factor Prospero (Pros) accumulates in the nucleus, signaling cell-cycle exit and terminal differentiation [1] . A recent study showed that the timing of neuroblast cell-cycle exit is regulated by a decrease in cell volume induced by the steroid hormone ecdysone and the Mediator complex [33] . To investigate whether Hippo signaling is required for timely neuroblast cell-cycle exit, we assessed the number and size of neuroblasts in the ventral nerve cord of pupal brains at the end of neurogenesis. Strikingly, loss of Tao-1 in neuroblasts results in an increased number of neuroblasts in pupal brains 24 hr APF (Figures 2L-2N) . Furthermore, the average diameter of the persistent neuroblasts was $19% larger than that of control neuroblasts ( Figure 2O ). Concomitant with this, loss of Tao-1 in neuroblasts resulted in an increased overall pupal brain volume compared with agematched control brains (Figures S3E-S3G ). We also assessed Pros localization in tao-1 RNAi clones of pupal ventral nerve cords at 24-26 hr APF. Most clones contained a single neuroblast at this time point (Figures S3H-S3H 00 ), and none of the persistent neuroblasts expressed Pros in the nucleus (arrow, Figure S3H 00 ). This suggests that Tao-1 depletion in neuroblasts delayed the onset of nuclear Pros localization and appropriate neuroblast cell-cycle exit. However, Tao-1-deficient neuroblasts do eventually exit the cell cycle and differentiate; in adult ventral nerve cords, we observed no evidence of persistent neuroblasts (marked by Mira) or proliferation (marked by pH3) in Tao-1-deficient clones ( Figures S3I-S3I 000 ). Collectively, our data show that Hippo pathway disruption expands the period that neuroblasts are engaged in the cell cycle and inhibits neuroblast growth both at the beginning and end of postembryonic neurogenesis.
The Hippo Pathway Restricts the Proliferative Capacity of Larval Neuroblasts by Limiting Cell-Cycle Speed
To further characterize the growth phenotype of type I neuroblast clones upon Hippo pathway disruption, we assessed cell death and proliferation. We found no evidence for altered cell death accounting for an increase in clone size, as no discernible difference in Death Caspase 1 or DIAP1 was observed in control or Tao-1-deficient clones ( Figures S4A-S4D 00 ). To assess proliferation in clones, we conducted an EdU feeding assay to assess (1) the number of EdU + cells and (2) which cells were proliferating. First, in both control and Tao-1-deficient clones, we consistently observed EdU incorporation in neuroblasts (marked by Mira in magenta, arrowhead, Figures 3A and 3B) and not in neurons (marked by Elav in red, arrowhead, Figures 3C and 3D ). Smaller cells located adjacent to Mira + neuroblasts that were EdU + but were marked by neither Elav nor Mira are most likely to be GMCs that either have inherited EdU from the neuroblast or may have divided in the 4 hr EdU feeding assay (arrow, Figures  3A-3D ). Importantly, in both control and Tao-1-deficient clones, EdU and Elav staining were mutually exclusive, indicating that neurons were not proliferating. Compared to control clones, we detected a significant increase in the number of EdU + cells in tao-1 RNAi clones ( Figure 3E ). In parallel, we also observed an increase in the mitotic index (marked by pH3) of neuroblasts in L3 brains expressing tao-1 RNAi versus control RNAi driven by dnab-Gal4, UAS-dicer in neuroblasts ( Figure 3F ). Altogether, these data suggest that upon Hippo pathway disruption, there is an overall increase in both cell proliferation and the mitotic index of neuroblasts due to a more rapid cell-cycle speed.
Quantification of phospho-Histone H3 + (pH3 + ) neuroblasts (NB) as a percentage of total neuroblasts in the ventral nerve cord of mid-L3 brains expressing either control b-galactosidase RNAi (Con; n = 5) or tao-1 (GD) RNAi (n = 7) driven by dnab-Gal4, UAS-dicer at 29 C is shown in (F). Mean ± SEM; ****p < 0.0001.
(G and H) Tao-1 restricts neuroblast cell-cycle speed. Quantification of cell-cycle time (G) or cell diameter (H) of neuroblasts from time-lapse confocal microscopy of either control or tao-1 RNAi MARCM clones in brains that were cultured ex vivo for $4.5 hr is shown (refer to Table S1 ). Mean ± SEM. In (G), n = 9 and 23; ****p < 0.0001. In (H), n = 15 and 36; ****p < 0.0001. (I-J) Snapshots from time-lapse confocal microscopy imaging showing successive cell divisions of neuroblasts in representative control (I-I 00 ) or tao-1 (J-J 0000 )
RNAi GFP + MARCM clones (refer to Table S1 ). Cell cycles were timed by nuclear envelope breakdown, when the nuclear GFP signal dispersed throughout the whole cell with a concomitant decrease in GFP signal intensity (neuroblasts are outlined by dashed gray line). Times are shown as hr:min. Scale bars, 5 mm. See also Figure S4 , Movies S1 and S2, and Table S1 .
To definitively confirm that the Hippo pathway is required to restrict neuroblast cell-cycle speed, we performed time-lapse imaging of brains cultured ex vivo. Early-L3 larval brains harboring control or tao-1 RNAi clones were cultured in a custom chamber for at least 5 hr and imaged by confocal microscopy (Movies S1 and S2). Cell-cycle times were measured as the period between successive nuclear envelope breakdowns, when the GFP signal disperses throughout the neuroblast. In control clones, the average neuroblast cell-cycle time was 1 hr 28 min (Movie S1; representative movie stills in Figure 3I ; quantified in Figure 3G from data in Table S1 ), comparable to that observed previously [22, 34] . In comparison, Tao-1-deficient neuroblasts divided significantly faster with an average cellcycle time of 59 min (Movie S2; representative movie stills in Figure 3J ; quantified in Figure 3G from data in Table S1 ). Furthermore, these faster Tao-1-deficient neuroblasts were $14% larger in diameter (mean of 12.28 mm; Figure 3H ) than their control counterparts (mean of 10.75 mm; Figure 3H ). These data demonstrate that the Hippo pathway restricts both the cell-cycle speed and cell size of neuroblasts during post-embryonic neurogenesis. This is consistent with observations in growing epithelial tissues, where the Hippo pathway regulates both cell size and cell-cycle speed [35] [36] [37] [38] [39] .
Defects in asymmetric cell division affect neuroblast selfrenewal and can lead to ectopic neuroblasts and brain overgrowth [14, 23, 40, 41] . Using our time-lapse data, we examined Tao-1-deficient clones to assess asymmetric cell division and whether ectopic neuroblast progenitors were produced. In both control and Tao-1-deficient clones, only one large neuroblast was observed to undergo asymmetric cell division (Movies S1 and S2; Figures S4F-S4M and S4N-S4O 000 ). Moreover, the smaller GMCs immediately adjacent to the neuroblast divided symmetrically in both control and Tao-1-deficient clones (Figures S4P and S4Q ). In concordance with this, in L3 brains that express tao-1 RNAi, hpo RNAi, or wts RNAi using dnab-Gal4, UAS-dicer, apical (marked by aPKC), and basal (marked by Mira) polarity markers were correctly localized in neuroblasts, in agreement with that observed in control brains (data not shown). Altogether, our data show that in L3 brain neuroblasts, asymmetric cell division is unaffected in the absence of Hippo signaling.
We also assessed whether the increased clonal volume could be explained by alterations in cell number and/or size. Compared to control clones, Tao-1-deficient clones contained a significant increase in neuron number ( Figure 3K) . Furthermore, the average cell diameter of neurons in Tao-1-deficient clones was reduced compared to controls ( Figure 3L ). This smaller neuronal cell diameter was also observed in wts XI mutant clones ( Figure S4E ). To investigate whether the Hippo pathway also influences neuronal identity, we quantified the number of early born (marked by Chinmo) and late born (marked by Broad Complex, Br-C) neurons [1] . We observed a significant increase in the absolute number of both Chinmo + and Br-C + sub-populations in the absence of Tao-1, and where control clones were composed of $30% Chinmo + cells (consistent with previous studies [1] ), Tao-1-deficient clones were composed of $50% Chinmo + neurons ( Figure S3M ). However, since both Chinmo and Br-C were expressed in control and Tao-1-deficient clones, we conclude that the Chinmo / Br-C temporal identity switch was unlikely to be affected in the absence of Tao-1. Altogether, these data show that Tao-1 normally restrains cell-cycle speed during postembryonic neurogenesis, resulting in an excess number of cells, which ultimately contributes to the overall increase in biomass produced by a single neuroblast.
The Hippo pathway Acts via Yorkie in Neuroblasts to Regulate Brain Size Yki is the key downstream transcriptional co-activator protein inhibited by the Hippo pathway to regulate epithelial organ size [42] . Therefore, we addressed whether Yki is important in controlling neuroblast cell proliferation and brain size. In epithelia, Yki overexpression phenocopies the loss of function of hpo, wts, or tao-1 [15, 42] . Consistent with this, neuroblast-specific expression of independent yki transgenes encoding either wild-type Yki or gain-of-function Yki (Yki S168A ) caused a substantial increase in the insc>GFP volume in the brain compared to the control ( Figures 4A-4D ), suggesting that elevation of Yki activity is sufficient to promote brain growth.
To examine the requirement of Yki during postembryonic neurogenesis, first, we performed genetic epistasis experiments to determine whether precocious neuroblast reactivation observed upon Tao-1 depletion was dependent on Yki. L1-L2 brains expressing tao-1 RNAi alone or together with yki RNAi driven by inscuteable-Gal4 were labeled with EdU for 1 hr. Co-expression of yki RNAi with tao-1 RNAi significantly blocked both precocious neuroblast reactivation from quiescence and increased brain volume caused by tao-1 RNAi expression alone ( Figures  4E-4J) . Second, we assessed the requirement of Yki downstream of the Hippo pathway in mid-L3 brains bearing MARCM clones that expressed yki RNAi in control or wts XI mutant clones ( Figures 4K-4O ). In the ventral nerve cord, yki RNAi clone volume was reduced compared to that of control clones ( Figures 4K-4L and 4O), similar to that observed in epithelia [42] . Furthermore, yki RNAi suppressed the increase in clone volume of wts XI mutant clones ( Figures 4M-4O) . Therefore, the Hippo pathway normally limits the proliferative capacity of neuroblasts by repressing Yki activity at the beginning of, and during, postembryonic neurogenesis.
Conclusions
The proliferative potential of NSCs is the key determinant of brain size [6, 8] . In the D. melanogaster brain, major mechanisms that control the proliferative potential of neuroblasts and the finite number of progeny they produce include (1) regulation of neuroblast asymmetric division [22] [23] [24] and (2) control of neuroblast terminal differentiation by temporal transcription factors [1, 43] , Ecdysone signaling, Mediator complex activity, and metabolism [33] . Here, we report the discovery of the Hippo pathway as an additional mechanism that controls the proliferative potential of neuroblasts and overall brain size. Specifically, the Hippo pathway constrains (1) neuroblast cell-cycle speed and size (when the Hippo pathway is impaired, neuroblasts are enlarged and produce more neurons) and (2) the overall developmental period in which neuroblasts proliferate (upon Hippo pathway deregulation, neuroblasts precociously re-enter the cell cycle from quiescence and delay cell-cycle exit at the end of postembryonic neurogenesis). Importantly, this shows that Hippo pathway disruption uncouples stem cell entry into the cell cycle from developmental timing and systemic tissue growth [30, 31] . Future studies should focus on how Hippo signaling interfaces with other regulators of neuroblast cell-cycle entry and exit, such as the Target of Rapamycin, Insulin, and Ecdysone pathways, and the Mediator complex. Further, it will be important to determine whether Hippo pathway activity is regulated by 
